Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 35
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

RECORDATI RARE

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 39
  • 0 comments

FDA approve PASIREOTIDE DIASPARTATE

Comment Full text

APOTEX

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 42
  • 0 comments

FDA approve ELIGLUSTAT TARTRATE

Comment Full text

IPSEN PHARMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 35
  • 0 comments

FDA approve LANREOTIDE ACETATE

Comment Full text

WATSON LABS

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 38
  • 0 comments

FDA approve HYDROXYCHLOROQUINE SULFATE

Comment Full text

HIKMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 37
  • 0 comments

FDA approve AZATHIOPRINE SODIUM

Comment Full text

MYLAN

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve FLUOXETINE HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • July 15, 2024, 08:49 UTC
  • 39
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • July 12, 2024, 09:02 UTC
  • 40
  • 0 comments

FDA approve ERTUGLIFLOZIN

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • July 12, 2024, 09:02 UTC
  • 39
  • 0 comments

FDA approve POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC

Comment Full text
  • Previous
  • 398
  • 399
  • 400
  • 401
  • 402
  • Next

Search

News categories

  • Technical Exchange News(11551)
  • Event(3597)
  • SEC News(218877)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(138721)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin